EGFR and cancer: Numerous empirical studies have verified that ErbB family/Grb7-regulated signaling contributes to the malignant characteristics of cancers, emphasizing Grb7 as a promising prognostic marker and a potential therapeutic target in ERBB family-mediated cancer.